| Name | 2-Cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)but-2-enamide,teriflunomide | 
|---|---|
| Synonyms | 2-Butenamide (2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl] Butanenitrile, 2-[hydroxy[[4-(trifluoromethyl)phenyl]amino]methylene]-3-oxo-, (2Z)- (2Z)-2-(Hydroxy{[4-(trifluoromethyl)phenyl]amino}methylene)-3-oxobutanenitrile 2-Cyano-3-hydroxy-N-(4-trifluoromethylphenyl)crotonamide Teriflunomide 2-Cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)but-2-enamide | 
| Description | (E/Z)-Teriflunomide ((E/Z)-A77 1726) is the active metabolite of Leflunomide (HY-B0083). Leflunomide is an immunomodulatory agent that may exert effects by inhibiting the mitochondrial enzyme dihydroorotate dehydrogenase (DHODH). Leflunomide can be used for the research of rheumatoid arthritis (RA)[1]. | 
|---|---|
| Related Catalog | 
| Density | 1.4±0.1 g/cm3 | 
|---|---|
| Boiling Point | 363.0±42.0 °C at 760 mmHg | 
| Molecular Formula | C12H9F3N2O2 | 
| Molecular Weight | 270.207 | 
| Flash Point | 173.3±27.9 °C | 
| Exact Mass | 270.061615 | 
| PSA | 73.12000 | 
| LogP | 0.71 | 
| Vapour Pressure | 0.0±0.9 mmHg at 25°C | 
| Index of Refraction | 1.552 | 
| Storage condition | +2C to +8C | 
| Symbol |   GHS07 | 
|---|---|
| Signal Word | Warning | 
| Hazard Statements | H302 | 
| Hazard Codes | Xn | 
| Risk Phrases | 22 | 
| RIDADR | NONH for all modes of transport |